Table 4. The AUC of each model validated in different pathological stages. Because sample size (n=9) of stage II in validation set is too small to evaluate, we combine stage I and II for analysis.
Model | AUC in stage I and II (n=63) | AUC in stage III (n=76) | AUC in stage IV (n=61) |
---|---|---|---|
MClinical | 0.630 | 0.800 | 0.617 |
MRadiomics | 0.755 | 0.742 | 0.736 |
MRadiomics+Clinical | 0.713 | 0.838 | 0.718 |
MMCNNs | 0.767 | 0.815 | 0.848 |
MMCNNs+Clinical | 0.800 | 0.860 | 0.847 |
MRadiomics+MCNNs | 0.771 | 0.818 | 0.839 |
MRadiomics+MCNNs+Clinical | 0.803 | 0.861 | 0.854 |
MCCNs, multi-level residual CNNs; CNN, convolutional neural network; AUC, area under the receiver operating characteristic curve.